ELAN News and Press, Elanco Animal Health Incorporated From 05/19/23

2023-05-19 08:52:55 ET Elanco Animal Health ( NYSE: ELAN ) will start distributing Tonisity International's gut enhancing swine products. Elanco said that in November 2022 it signed a distribution and promotion agreement with Ireland-based Tonisity for  novel, gut en...

2023-05-16 11:13:59 ET One way to find potential growth investments is to look at stocks that analysts are bullish about. They spend a lot of time analyzing businesses, and they set price targets for where they expect stocks to be within the next 12 to 18 months. While you should always tak...

2023-05-14 06:00:00 ET Stock Traders Daily has produced this trading report using a proprietary method.  This methodology seeks to optimize the entry and exit levels to maximize results and limit risk, and it is also applied to Index options, ETFs, and futures for our subscribers. This...

2023-05-09 18:30:46 ET Image source: The Motley Fool. Elanco Animal Health (NYSE: ELAN) Q1 2023 Earnings Call May 09, 2023 , 8:00 a.m. ET Operator Continue reading For further details see: Elanco Animal Health (ELAN) Q1 2023 Earnings Call...

2023-05-09 13:22:08 ET Elanco Animal Health Inc. (ELAN) Q1 2023 Results Conference Call May 09, 2023 09:00 AM ET Company Participants Katy Grissom - Head of Investor Relations Jeff Simmons - President and Chief Executive Officer Todd Young - Chief Financial Offic...

2023-05-09 06:35:41 ET Elanco press release ( NYSE: ELAN ): Q1 Non-GAAP EPS of $0.45 beats by $0.16 . Revenue of $1.26B (+2.4% Y/Y) beats by $80M . Net leverage ratio of 5.4x Adjusted EBITDA Raising the bottom end of full year 2023 guidance ranges to reflec...

First Quarter 2023 Financial Results Revenue of $1,257 million, including an estimated $90-$110 million benefit from customer purchasing shifted from the second quarter into the first as a result of ERP system commercial ordering blackout period for legacy Bayer Animal Health products...

Targeted single-dose monoclonal antibody is the first and only treatment for devastating dog disease Elanco Animal Health Incorporated (NYSE: ELAN) today announced the U.S. Department of Agriculture (USDA) has provided a conditional license for the first Canine Parvovirus Monoclonal Ant...

California Dairies, Inc. and DSM Venturing Complete Strategic Investment in Athian PR Newswire Athian's livestock carbon credit marketplace completes latest round of funding thanks to the investment by California Dairies, Inc. and DSM Venturing INDIANAPOLIS ,...

2023-04-28 14:18:29 ET Summary Elanco Animal Health finally saw its stock price decline steep after it was trading for extremely high valuation multiples for a long time. Additionally, Elanco Animal Health still has extremely high debt levels. Results for fiscal 2022 were not ...